NDC 0002-8980

Rezvoglar KwikPen

Insulin Glargine-aglr

Rezvoglar KwikPen is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Insulin Glargine.

• Product ID: 0002-8980_446fd274-f4e5-4f9f-9be4-0c9d74f3b14e
• NDC: 0002-8980
• Product Type: Human Prescription Drug
• Proprietary Name: Rezvoglar KwikPen
• Generic Name: Insulin Glargine-aglr
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2021-12-17
• Marketing Category: BLA /
• Application Number: BLA761215
• Labeler Name: Eli Lilly and Company
• Substance Name: INSULIN GLARGINE
• Active Ingredient Strength: 100 [iU]/mL
• Pharm Classes: Insulin Analog [EPC], Insulin [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0002-8980-05

5 SYRINGE in 1 CARTON (0002-8980-05) > 3 mL in 1 SYRINGE (0002-8980-01)

• Marketing Start Date: 2021-12-17
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details